Search hospitals > Massachusetts > Gloucester
Addison Gilbert Hospital
Claim this profileGloucester, Massachusetts 01930
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast cancer
95 reported clinical trials
9 medical researchers
Summary
Addison Gilbert Hospital is a medical facility located in Gloucester, Massachusetts. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. Addison Gilbert Hospital is involved with conducting 95 clinical trials across 139 conditions. There are 9 research doctors associated with this hospital, such as Corrine Zarwan, MD, Brendan Connell, Paul J. Hesketh, and Andrew Piper-Vallillo.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
PR positive
HER2 negative
Top PIs
Corrine Zarwan, MDLahey Hospital and Medical Center8 years of reported clinical research
Expert in Skin Cancer
Studies Breast Cancer
16 reported clinical trials
47 drugs studied
Brendan ConnellLahey Hospital and Medical Center5 years of reported clinical research
Studies Skin Cancer
Studies Lung Cancer
14 reported clinical trials
38 drugs studied
Paul J. HeskethLahey Hospital and Medical Center5 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
13 reported clinical trials
21 drugs studied
Andrew Piper-VallilloLahey Hospital and Medical Center2 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
4 reported clinical trials
13 drugs studied
Clinical Trials running at Addison Gilbert Hospital
Breast Cancer
Lung Cancer
Breast cancer
Non-Small Cell Lung Cancer
Skin Cancer
Bladder Cancer
Kidney Cancer
ALK Gene Rearrangement
Squamous Cell Carcinoma
Colon Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Addison Gilbert Hospital?
Addison Gilbert Hospital is a medical facility located in Gloucester, Massachusetts. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. Addison Gilbert Hospital is involved with conducting 95 clinical trials across 139 conditions. There are 9 research doctors associated with this hospital, such as Corrine Zarwan, MD, Brendan Connell, Paul J. Hesketh, and Andrew Piper-Vallillo.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.